Publication | Open Access
Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma
56
Citations
39
References
2018
Year
1. Distinct genomic profiles of 19 adult cerebellar GBMs were characterized. 2. MEK inhibitor was highly sensitive to cerebellar GBM compared with supratentorial GBM. 3. Master regulator analysis revealed NR4A1 as a potential therapeutic target in cerebellar GBM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1